Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

Completed · Not applicable

Conditions studied: Atypical Squamous Cell of Undetermined Significance, Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Health Status Unknown, Human Papillomavirus Infection, Low Grade Cervical Squamous Intraepithelial Neoplasia, Stage 0 Cervical Cancer

In brief

This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.

Key facts

Study ID

NCT01550783

Run by

University of Washington

People needed

1335

Starts

2012-03-01

Expected to finish

2017-11-16

Last updated by the study team

2020-07-31

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Able to provide informed consent in English

You may not qualify if…

• Have had hysterectomy
• Currently pregnant
• Received treatment of cervical dysplasia with LEEP, cone biopsy, laser procedure or cryotherapy within THREE years
• Received colposcopy of cervix within TWO years
• Received Pap test within ONE year
• Immunocompromised (positive human immunodeficiency virus [HIV] test, transplant recipient, received chemotherapy for cancer, or taking immunosuppressant drugs)
• Decisionally impaired adults requiring a legally authorized representative

Where it is running

• University of Minnesota/Masonic Cancer Center — Minneapolis, Minnesota, United States
• Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.